Pavan Cheruvu - Net Worth and Insider Trading
Pavan Cheruvu Net Worth
The estimated net worth of Pavan Cheruvu is at least $86,244 dollars as of 2024-05-08. Pavan Cheruvu is the CEO of Sio Gene Therapies Inc and owns about 180,426 shares of Sio Gene Therapies Inc (SIOX) stock worth over $86,244. Details can be seen in Pavan Cheruvu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pavan Cheruvu has not made any transactions after 2021-03-23 and currently still holds the listed stock(s).
Transaction Summary of Pavan Cheruvu
Pavan Cheruvu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pavan Cheruvu owns 1 companies in total, including Sio Gene Therapies Inc (SIOX) .
Click here to see the complete history of Pavan Cheruvu’s form 4 insider trades.
Insider Ownership Summary of Pavan Cheruvu
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SIOX | Sio Gene Therapies Inc | 2021-03-23 | Chief Executive Officer |
Pavan Cheruvu Latest Holdings Summary
Pavan Cheruvu currently owns a total of 1 stock. Pavan Cheruvu owns 180,426 shares of Sio Gene Therapies Inc (SIOX) as of March 23, 2021, with a value of $86,244.
Latest Holdings of Pavan Cheruvu
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SIOX | Sio Gene Therapies Inc | 2021-03-23 | 180,426 | 0.48 | 86,244 |
Holding Weightings of Pavan Cheruvu
Pavan Cheruvu Form 4 Trading Tracker
According to the SEC Form 4 filings, Pavan Cheruvu has made a total of 3 transactions in Sio Gene Therapies Inc (SIOX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Sio Gene Therapies Inc is the acquisition of 100,000 shares on March 23, 2021, which cost Pavan Cheruvu around $248,000.
Insider Trading History of Pavan Cheruvu
- 1
Pavan Cheruvu Trading Performance
GuruFocus tracks the stock performance after each of Pavan Cheruvu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pavan Cheruvu is 32.94%. GuruFocus also compares Pavan Cheruvu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pavan Cheruvu within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pavan Cheruvu's insider trading performs compared to the benchmark.
Performance of Pavan Cheruvu
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.41 | | | | | |
| Relative Return to S&P 500(%) | 12.74 | | | | | |
Pavan Cheruvu Ownership Network
Pavan Cheruvu Owned Company Details
What does Sio Gene Therapies Inc do?
Who are the key executives at Sio Gene Therapies Inc?
Pavan Cheruvu is the Chief Executive Officer of Sio Gene Therapies Inc. Other key executives at Sio Gene Therapies Inc include Chief Commercial Officer Parag V Meswani , 10 percent owner Roivant Sciences Ltd. , and Principal Financial Officer David W. Nassif .
Sio Gene Therapies Inc (SIOX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sio Gene Therapies Inc (SIOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sio Gene Therapies Inc (SIOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sio Gene Therapies Inc (SIOX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sio Gene Therapies Inc Insider Transactions
Pavan Cheruvu Mailing Address
Above is the net worth, insider trading, and ownership report for Pavan Cheruvu. You might contact Pavan Cheruvu via mailing address: C/o Axovant Sciences, Inc., 11 Times Square, 33rd Floor, New York Ny 10036.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
